Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Promovenda Anke Wijers over op afstand monitoren van Parkinson
aug 2022 | Bewegingsstoornissen